Table 3.
Outcome measures at baseline, week-2, and week-4 of the two groups.
| Outcome measure | CT group | RT group | ||||
|---|---|---|---|---|---|---|
| Week 0 | Week 2 | Week 4 | Week 0 | Week 2 | Week 4 | |
| Motor function | ||||||
| FMA-UE total | 15.42 ± 8.74 | 17.79 ± 9.28 | 20.21 ± 9.64 | 15.92 ± 8.60 | 20.50 ± 9.81 | 23.83 ± 11.02 |
| FMA-UE Shoulder & Elbow | 11.88 ± 5.14 | 13.92 ± 5.08 | 15.79 ± 5.27 | 12.00 ± 5.31 | 15.75 ± 6.15 | 18.33 ± 6.81 |
| FMA-UE Wrist | 0.75 ± 1.62 | 0.75 ± 1.75 | 0.79 ± 1.74 | 0.83 ± 1.86 | 0.96 ± 2.05 | 1.08 ± 2.50 |
| FMA-UE Hand | 2.46 ± 3.12 | 2.83 ± 3.33 | 3.33 ± 3.67 | 3.08 ± 3.41 | 3.75 ± 3.69 | 4.42 ± 3.92 |
| Daily activity | ||||||
| BI-total score | 56.21 ± 16.26 | 61.21 ± 13.70 | 64.67 ± 14.59 | 59.13 ± 13.71 | 61.79 ± 12.30 | 66.33 ± 11.82 |
| BI-Involving upper limbs | 15.83 ± 5.20 | 18.13 ± 3.68 | 19.33 ± 4.85 | 17.21 ± 4.49 | 19.25 ± 3.69 | 20.58 ± 3.04 |